Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
Eligible age
18+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.
Sponsor: University of California, Los Angeles
You may qualify if…
- ✓ Prenatal care at UCLA Health
- ✓ Planning to deliver at UCLA Ronald Reagan or UCLA Santa Monica
- ✓ Confirmed gestational diabetes diagnosis based on 2-step approach
- ✓ Maternal age \>= 18 years
You may not qualify if…
- ✕ Pre-gestational diabetes (T1DM or T2DM)
- ✕ Multifetal gestation
- ✕ Intra-amniotic infection by clinical criteria
- ✕ Postpartum hemorrhage
- ✕ Maternal ICU admission
- ✕ Known allergy to medical-grade adhesive
- ✕ Presence of skin lesions at anticipated CGM application site
- ✕ Scheduled postpartum non-sonographic imaging study (radiograph, magnetic resonance imaging (MRI), or computed tomography (CT) scan) during trial
Where it's recruiting
Los Angeles
Source: ClinicalTrials.gov · NCT07449039 · last updated 2026-03-04